Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that…
Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare progressive brain disorder that can impact children and adults. In children, DRPLA…
L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays…
For more information
If you are interested in seeing how Redenlab can help your organisation, please fill in the form and we’ll get in contact with you.
